Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), μ opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))

Genomics

Volumn 52, Issue 3, 1998, Pages 289-297

  Gelernter, Joel ^a,b   Kranzler, Henry ^c   Lacobelle, James ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CILIARY NEUROTROPHIC FACTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; MU OPIATE RECEPTOR; TRYPTOPHAN HYDROXYLASE;

ARTICLE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPULSIVENESS; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHIZOPHRENIA; SUICIDE;

EID: 0032531204     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5454     Document Type: Article

References (77)

1. Asberg, M., Schalling, D., and Traskman-Bendz, L. (1987). Psychobiology of suicide, impulsivity, and related phenomena. In "Psychopharmacology: The Third Generation of Progress" (H. Y. Meltzer, Ed.), pp. 665-668, Raven Press, New York.
2. Bergen, A. W., Kokoszka, J., Peterson, R., Long, J. C., Virkkunen, M., Linnoila, M., and Goldman, D. (1997). μ opioid receptor gene variants: Lack of association with alcohol dependence. Mol. Psychiatry 2: 490-494.
3. Berrettini, W. H., Hoehe, M. R., Ferraro, T. N., DeMaria, P. A., and Gottheil, E. (1997). Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict. Biol. 2: 303-308.
4. Bouthenet, M. L., Souil, E., Martres, M. P., Sokoloff, P., Giros, B., and Schwartz, J-C. (1991). Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA. Brain Res. 564: 203-219.
5. Caine, S. B., and Koob, G. F. (1993). Modulation of cocaine self administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816.
6. Coccaro, E. F., and Murphy, D. L. (Eds.) (1990). "Serotonin in Major Psychiatric Disorders," Am. Psychiatric Press, Washington, DC.
7. Cook, E. H., Jr., Stein, M. S., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., and Leventhal, B. L. (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56: 993-996.
8. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Jr., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7: 180-184.
9. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
10. Crocq, M-A., Mant, R., Asherson, P., Williams, J., Hode, Y., Mayerova, D., Collier, D., Lannfelt, L., Sokoloff, P., Schwartz, J-C., Gill, M., Macher, J-P., McGuffin, P., and Owen, M. J. (1992). Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 29: 858-860.
11. Cubells, J. F., Kobayashi, K, Nagatsu, T., Kidd, K. K., Kidd, J. R., Calafell, F., Kranzler, H., Ichinose, H., and Gelernter, J. (1997). Population genetics of a functional variant of the dopamine β-hydroxylase gene (DBH). Am. J. Med. Genet. (Neuropsych. Genet.) 74: 374-379.
12. Dean, M., Stephens, J. C., Winkler, C., Lomb, D. A., Ramsburg, M., Boaze, R., Stewart, C., Charbonneau, L., Goldman, D., Albaugh, B. J., Goedert, J. J., Beasley, R. P., Hwang, L-Y., Buchbinder, S., Weedon, M., Johnson, P. A., Eichelberger, M., and O'Brien, S. J. (1994). Polymorphic admixture typing in human ethnic populations. Am. J. Hum. Genet. 55: 788-808.
13. Doucette-Stamm, L. A., Blakely, D. J., Tian, J., Mockus, S., and Mao, J. (1995). Population genetic study of the human dopamine transporter gene (DAT1). Genet. Epidemiol. 12: 303-308.
14. Falk, C. T., and Rubinstein, P. (1987). Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51: 227-233.
15. Freimer, M., Kranzler, H., Satel, S., Lacobelle, J., Skipsey, K., Charney, D. S., and Gelernter, J. (1996). No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict. Biol. 1: 281-287.
16. 2 dopamine receptor gene (DRD2) and alcoholism. JAMA 266: 1801-1807.
17. Gelernter, J., Kranzler, H. R., Satel, S. L., and Rao, P. A. (1994). Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11: 195-200.
18. Gelernter, J., and Crowe, R. R. (1997). Candidate genes and psychiatric genetics: Tomorrow never knows. Psychiatric Ann. 27: 262-267.
19. Gelernter, J., Van Dyck, C., van Kammen, D. P., Malison, R., Price, L. H., Cubells, J., Berman, R., Charney, D. S., and Heninger, G. (1997a). Ciliary neurotrophic factor null allele frequency in schizophrenia, affective disorders, and Alzheimer's disease. Am. J. Med. Genet. (Neuropsych. Genet.) 74: 497-500.
20. Gelernter, J., Kranzler, H., and Cubells, J. F. (1997b). Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African and European American and Japanese populations and in alcohol dependent subjects. Hum. Genet. 101: 243-246.
21. Gelernter, J., Cubells, J. F., Kidd, J. R., Pakstis, A. J., and Kidd, K. K. (1998a). Population studies of polymorphisms of the serotonin transporter protein gene. Am. J. Med. Genet. (Neuropsych. Genet.), in press.
22. 2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder (PTSD). Biol. Psychiatry, in press.
23. 3 receptor gene: Organization, transcript variants, and polymorphism associated with schizophrenia. Am. J. Med. Genet. (Neuropsych. Genet.) 67: 63-70.
24. Haldane, J. B. S. (1964). A defense of beanbag genetics. Perspect. Biol. Med. 7: 343-359. [Reprinted in "Selected Genetic Papers of J. B. S. Haldane" (K. R. Dronamraju, Ed.), Garland, New York and London, 1990]
25. Hallman, D. M., Boerwinkle, E., Saha, N., Sandholzer, C., Menzel, H. J., Csazar, A., and Utermann, G. (1991). The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49: 338-349.
26. Hixson, J. E., and Vernier, D. T. (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
27. Ip, N. Y., Li, Y. P., van de Stadt, I., Panayotatos, N., Alderson, R. F., and Lindsay, R. M. (1991). Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J. Neurosci. 11: 3124-3134.
28. Jönsson, E., Lannfelt, L., Sokoloff, P., Schwartz, J-C., and Sedvall, G. (1993). Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr. Scand. 87: 345-349.
29. Kidd, J. R., Black, F. L., Weiss, K. M., Balazs, I., and Kidd, K. K. (1991). Studies of three Amerindian populations using nuclear DNA polymorphisms. Hum. Biol. 63: 775-794.
30. Kranzler, H. A., Gelernter, J., O'Malley, S., Hernandez-Avila, C. A., and Kaufman, D. (1998). Association of alcohol or other drug dependence with alleles of the μ opioid receptor (OPRM1). Alcohol Clin. Exp. Res., in press.
31. Krontiris, T. G. (1995). Minisatellites and human disease. Science 269: 1682-1683.
32. Lahiri, D. K., and Nurnberger, J. I. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 9: 5444.
33. Lannfelt, L., Sokoloff, P., Martres, M. P., Pilon, C., Giros, B., Jonsson, E., Sedvall, G., and Schwartz, J-C. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr. Genet. 2: 249-256.
34. Le Coniat, M., Sokoloff, P., Hillion, J., Martres, M-P., Giros, B., Pilon, C., Schwartz, J-C., and Berger, R. (1991). Chromosomal localization of the human D-3 dopamine receptor gene. Hum. Genet. 87: 618-620.
35. Ledley, F. D., Grenett, H. E., Bartos, D. P., van Tuinen, P., Ledbetter, D. H., and Woo, S. L. (1987). Assignment of human tryptophan hydroxylase locus to chromosome 11: Gene duplication and translocation in evolution of aromatic amino acid hydroxylases. Somatic Cell Mol. Genet. 13: 575-580.
36. Lev, A. A., Rosen, D. R., Kos, C., Clifford, E., Landes, G., Hauser, S. L., and Brown, R. H., Jr. (1993). Human ciliary neurotrophic factor: Localization to the proximal region of the long arm of chromosome 11 and association with CA/GT dinucleotide repeat. Genomics 16: 539-541.
37. Lewis, P. O., and Zaykin, D. (1997). Genetic data analysis: Computer program for the analysis of allelic data. Version 1.0. Free program distributed by the authors over the Internet from the GDA home page at http://chee.unm.edu/gda/.
38. Li, T., Vallada, H., Bell, R., Liu, X., Xie, T., and Collier, D. A. (1996). CNTF and psychiatric disorders [letter]. Nat. Genet. 13: 143-144.
39. Maestre, G., Ottman, R., Stern, Y., Gurland, B., Chun, M., Tang, M-X., Shelanski, M., Tycko, B., and Mayeux, R. (1995). Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks. Ann. Neurol. 37: 254-259.
40. Mann, J. J., Malone, K. M., Nielsen, D. A., Goldman, D., Erdos, J., and Gelernter, J. (1997). Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am. J. Psychiatry 154: 1451-1453.
41. Mant, R., Williams, J., Asherson, P., Parfitt, E., McGuffin, P., and Owen, M. J. (1994). Relationship between homozygosity at the dopamine D3 receptor and schizophrenia. Am. J. Med. Genet. 54: 21-26.
42. Nanko, S., Sasaki, T., Fukuda, R., Hattori, M., Dai, X. Y., Kazamatsuri, H., Kuwata, S., et al. (1993). A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum. Genet. 92: 336-338.
43. Nei, M. (1972). Genetic distance between populations. Am. Nat. 106: 283-292.
44. New, A. S., Gelernter, J., Yovell, Y., Trestman, R. L., Nielsen, D. A., Silverman, J., Mitropoulou, V., and Siever, L. J. (1998). Tryptophan hydroxylase genotype is associated with impulsive aggression measures: A preliminary study. Am. J. Med. Genet. (Neuropsych. Genet.) 81: 13-17.
45. Nielsen, D. A., Dean, M., and Goldman, D. (1992). Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am. J. Hum. Genet. 51: 1366-1371.
46. Nielsen, D. A., Goldman, D., Virkkunen, M., Tokola, R., Rawlings, R., and Linnoila, M. (1994). Suicidality and 5-hydroxyindolacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch. Gen. Psychiatr. 51: 34-38.
47. Nielsen, D. A., Jenkins, G. L., Stefanisko, K. M., Jefferson, K. K., and Goldman, D. (1997). Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Mol. Brain Res. 45: 145-148.
48. Nimgaonkar, V. L., Zhang, X. R., Caldwell, J. G., Ganguli, R., and Chakravarti, A. (1993). Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: Probable effects of family history of schizophrenia? Am. J. Med. Genet. 48: 214-217.
49. Nöthen, M. M., Cichon, S., Eggermann, K., Propping, P., Knapp, M., Maier, W., and Rietschel, M. (1996). CNTF and psychiatric disorders [letter]. Nat. Genet. 13: 142-143.
50. Olaisen, B., Teisberg, P., and Gedde-Dahl, T., Jr. (1982). The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum. Genet. 62: 233-236.
51. Online Mendelian Inheritance in Man (OMIM). (1998). The Human Genome Data Base Project, Johns Hopkins Univ., Baltimore. [World Wide Web: http://gdbwww.gdb.org/omim/docs/omimtop.html]
52. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., and Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry 49: 881-887.
53. Ott, J. (1991). "Analysis of Human Genetic Linkage," rev. ed., Johns Hopkins Univ. Press, Baltimore.
54. Rietschel, M., Nöthen, M. M., Lannfelt, L., Sokoloff, P., Schwartz, J-C., Lanczik, M., and Fritze, J. (1993). A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: No role in the genetic predisposition to bipolar affective disorder. Psychiatry Res. 46: 253-259.
55. Sander, T., Harms, H., Podschus, J., Finckh, U., Nickel, B., Rolfs, A., Rommelspacher, H., and Schmidt, L. G. (1997). Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry 41: 299-304.
56. Sandholzer, C., Delport, R., Vermaak, H., and Utermann, G. (1995). High frequency of the apo ∈4 allele in Khoi San from South Africa. Hum. Genet. 95: 46-48.
57. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A. D. (1993). Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
58. 9 allele of the dopamine transporter gene. Am. J. Psychiatry 155: 474-478.
59. Sham, P. C., and Curtis, D. (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59: 97-105.
60. Spielman, R. S., McGinnis, R. E., and Ewens, W. J. (1993). Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52: 506-16.
61. Spiess, E. B. (1989). "Genes in Populations," 2nd ed., Wiley, New York.
62. Takahashi, R., Yokoji, H., Misawa, H., Hayashi, M., Hu, J., and Deguchi, T. (1994). A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7: 79-84.
63. Tang, M. X., Maestre, G., Tsai, W. Y., Liu, X. H., Feng, L., Chung, W. Y., and Chun, M. (1996). Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am. J. Hum. Genet. 58: 574-584.
64. Thome, J., Kornhuber, J., Baumer, A., Rösler, M., Beckmann, H., and Riederer, P. (1996a). CNTF and endogenous psychoses? [letter]. Nat. Genet. 12: 123.
65. Thome, J., Kornhuber, J., Baumer, A., Rösler, M., Beckmann, H., and Riederer, P. (1996b). Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? Neurosci. Lett. 203: 109-110.
66. Thome, J., Rösler, M., Riederer, P., and Kornhuber, J. (1996c). In reply - CNTF and psychiatric disorders [letter]. Nat. Genet. 13: 144.
67. Tiret, L., and Cambien, F. (1995). Departure from Hardy-Weinberg equilibrium should be systematically tested in studies of association between genetic markers and disease [letter]. Circulation 92: 3364.
68. Tishkoff, S. A., Dietzsch, E., Speed, W., Pakstis, A. J., Kidd, J. R., Cheung, K., Bonné-Tamir, B., Santachiara-Benerecetti, A. S., Moral, P., Krings, M., Pääbo, E., Watson, E., Risch, N., Jenkins, T., and Kidd, K. K. (1996). Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 271: 1380-1387.
69. Tsai, M. S., Tangalos, E. G., Petersen, R. C., Smiteh, G. E., Schaid, D. J., Kokmen, E., Ivnik, R. J., and Thibodeau, S. N. (1994). Apolipoprotein E: Risk factor for Alzheimer's disease. Am. J. Hum. Genet. 54: 643-649.
70. Undlien, D. E., Hamaguchi, K., Kimura, A., Tuomilehto-Wolf, E., Swai, A. B. M., McLarty, D. G, Tuomilehto, J., et al. (1994). IDDM susceptibility associated with polymorphisms in the insulin gene region: A study of blacks, Caucasians, and Orientals. Diabetologia 37: 745-749.
71. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., and Uhl, G. R. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106.
72. Volpicelli, J. R., Alterman, A. I., Hayashida, M., and O'Brien, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49: 876-880.
73. Wang, J-B., Johnson, P. S., Persico, A. M., Hawkins, A. L., Griffin, C. A., and Uhl, G. R. (1994). Human mu opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338: 217-222.
74. Weiner, J. (1994). "The Beak of the Finch," p. 288, Knopf, New York.
75. Weir, B. S. (1996). "Genetic Data Analysis. II. Methods for Discrete Population Genetic Data," Sinauer, Sunderland, MA.
76. Weisgraber, K. H., Rall, S. C., Jr., and Mahley, R. W. (1981). Human E apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256: 9077-9083.
77. Yang, L., Li, T., Wiese, C., Lannfelt, L., Sokoloff, P., Xu, C. T., Zeng, Z., Schwartz, J-C., Liu, X., and Moises, H. W. (1993). No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am. J. Med. Genet. 48: 83-86.